Patent intelligence · US
US 8835505
Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
Patent details — US 8835505
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 16, 2014
- Expiration
- Sep 11, 2034
- Applicant
- Welgrace Research Group
- Claims
- 18
- CPC classes
- A61K, A61K31/195, A61K31/216, A61K47/10
Quick answer
US 8835505 (Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container) is held by Welgrace Research Group. Status: granted. Granted Sep 16, 2014. Expires Sep 11, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Welgrace Research Group
- Grant date
- Expiration
- Claims
- 18
- CPC classes
- A61K, A61K31/195, A61K31/216, A61K47/10, A61K47/12, A61K9/0019
More from Welgrace Research Group
Related pharmaceutical patents in our USPTO index.
-
US 12414943
Nimodipine parenteral administration
granted -
US 12049487
Universal chimeric antigen receptor T-cell preparation technique
granted -
US 11840575
Engineered immune cells targeting BCMA and their uses thereof
granted -
US 11484501
Mechanochemical activated dry amorphisation by milling equilibrium between ap mesoporous silica
granted -
US 11478424
Mechanochemcial activated dry amorphisation by milling equilibrium between AP mesoporous silica
granted -
US 11478420
Vaginal probiotic products and related processes
granted -
US 11291672
Betamethasone oral spray formulation and method of use to treat ataxia
granted -
US 11052029
Cation compatible metal oxides and oral care compositions containing the metal oxides
granted
Frequently asked questions
What is US patent 8835505?
US 8835505 (Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container) is held by Welgrace Research Group. Status: granted. Granted Sep 16, 2014. Expires Sep 11, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8835505?
Welgrace Research Group is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 34 pharmaceutical patents for this assignee.
When does US 8835505 expire?
Our index shows an expiration date of Sep 11, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.